Found "AI": 1,118 results
Sort by
Relevance

Human Papillomavirus Vaccine introduction in low and middle Income countries guidance on the use of Cost-effectiveness models.(2011)

Human papillomavirus vaccine introduction in low and middle income countries: guidance on the use of cost-effectiveness models Mark Jit1, Nadia Demarteau2†, Elamin Elbasha3†, Gary Ginsberg4†, Jane Kim5†, Naiyana Praditsitthikorn6†, Edina Sinanovic7† and Raymond Hutubessy8* † Contributed equally 8

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions.(2011)

The EVIDEM framework and its usefulness for priority setting across a broad range of health interventions Download at http://www.resource-allocation.com/content/9/1/8 Sitaporn Youngkong1,2*, Noor Tromp1† and Dereck Chitama1,3† * Corresponding author: Sitaporn Youngkong [email protected]

Assessing key model parameters for economic evaluation of pandemic influenza interventions: the data source matters. (2013)

Assessing key model parameters for economic evaluation of pandemic influenza interventions: the data source matters. Naiyana Praditsitthikorn,a,b Surachai Kotirum,a Adun Mohara,a Kuntika Dumrongprat,a Roman Perez Velasco,c Yot Teerawattananona aHealth Intervention and Technology Assessment P

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund (2013)

Health technology assessments as a mechanism for increased value for money: recommendations to the Global Fund. Yot Teerawattananon1*, Kate McQueston2, Amanda Glassman2, Jomkwan Yothasamut1,2 and Chaw Yin Myint1,2 Abstract The Global Fund is experiencing increased pressure to optimize resul

Risk Factors of Breast Cancer: A Systematic Review and Meta-Analysis (2013)

Risk Factors of Breast Cancer: A Systematic Review and Meta-Analysis Thunyarat Anothaisintawee, MD1, Cholatip Wiratkapun, MD1, Panuwat Lerdsitthichai, MD, MSc1, Vijj Kasamesup, MD, PhD1, Sansanee Wongwaisayawan, MD1, Jiraporn Srinakarin, MD2, Siriporn Hirunpat, MD3, Piyanoot Woodtichartpreech

Involvement of consumers in health technology assessment activities by INAHTA agencies (2013)

Involvement of consumers in health technology assessment activities by INAHTA agencies. David Haileya1, Sophie Werköa2, Rugayah Bakria3, Alun Camerona4, Britta Göhlena5, Susan Mylesa6, Jasmine Pwua7 and Jomkwan Yothasamuta8 For the INAHTA Working Group on Impact of HTA a1 University of Wollong

Special English Edition of HITAP newsletter (Jan-Apr 2016) : Priority Setting for Universal Health Coverage

This issue of the HITAP Newsletter offers articles and stories of priority setting in the context of real world examples and practices that relate to the development of a benefits package for UHC. We hope to bring our readers towards a closer understanding of the means with which we can achieve equi

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. (2013)

Variation of health-related quality of life assessed by caregivers and patients affected by severe childhood infections. Wantanee KulpengEmail author, Vorasith Sornsrivichai, Virasakdi Chongsuvivatwong, Waranya Rattanavipapong, Pattara Leelahavarong, John Cairns, Yoel Lubell and Yot Teerawattanan

Health Care Coverage Decision Making in Low- and Middle-Income Countries: Experiences from 25 Coverage Schemes (2014)

Hialy Gutierrez, MPH,1,2 Ashwini Shewade, MS, MSc,1 Minghan Dai, MPH,1 Pedro Mendoza-Arana, MD, MSc,3 Octavio Go´mez-Dante´s, MD, MPH,4 Nishant Jain, PhD,5 Irma Khonelidze, MPA,6 Juliet Nabyonga-Orem, MD, MSc,7 Karima Saleh, PhD,8 Yot Teerawattananon, MD, PhD,9 Sania Nishtar, SI, PhD,10 and John Hor

Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable (PEN) disease interventions in Bhutan. (2014)

In response to a lack of cost-effective data on screening and early treatment of diabetes and hypertension in resource-limited settings, a model-based economic evaluation was performed on the World Health Organization (WHO)’s Package of Essential Non-communicable (PEN) disease interventions for prim
10 / Page